Skip to content
SurenoGet Sureno Browser
← Sureno News

Scientists fighting to replace halted funds as trust in Black communities grows harder to win back

A study left unfinished

Residents in Pittsburgh’s Hill and Homewood neighborhoods took memory tests, tracked sleep and blood pressure, and shared personal histories as part of research into Alzheimer’s risks. The study examined why Black Americans are twice as likely as white Americans to develop the disease.

The National Institutes of Health ended its funding last year, during the study’s fifth and final year. Researchers say more than $8 million in taxpayer money had already been spent, and participants may never learn what their brain tests showed. Roderick Blair, who took part for four years, said residents could feel researchers had collected information and then left them without answers.

Trust built through participation

Trust in U.S. health institutions has been strained by racial inequities, unequal access to care and bias in medicine. The history of the Tuskegee study, which withheld treatment from Black men with syphilis in the 1930s, remains part of that legacy.

Pittsburgh field coordinator La’Vette Wagner said community involvement helped residents discuss memory loss, dementia and Alzheimer’s, and challenged misconceptions. Some families who had attributed memory problems to depression began asking about dementia, she said. The Alzheimer’s Association reports that 55% of Black Americans believe major memory or cognitive decline is a natural part of aging, rather than a disease.

Other research also halted

At Emory University in Atlanta, neuropsychologist Negar Fani’s five-year project examined how daily racial discrimination affects Black Americans’ brains and bodies. NIH terminated the $2.9 million project in July, two years in, after 66 of 220 planned participants had enrolled.

Fani is seeking roughly $2.3 million to finish the work. She and her team have also had to explain the termination to participants, some of whom feel abandoned. Researchers said both projects were labeled “not scientific.” Wagner said the Pittsburgh study was not a Black or DEI project, but research into a real issue.

Legal challenge and funding shift

Pittsburgh study lead researcher Andrea Rosso is among scientists suing NIH and the Department of Health and Human Services. The lawsuit is part of a growing set of legal actions against grant terminations involving descriptions such as “disparities,” “minority” and “racial.” Ann Cohen, a director of Pittsburgh’s Alzheimer’s Disease Research Center, joined the lawsuit after a separate, complementary study of Alzheimer’s risk was halted. That project had spent $5.2 million over three years, and Cohen is considering what to do with participants’ blood samples.

An HHS spokesperson said NIH is redirecting money toward rigorous research intended to improve health outcomes. A report from the Association of American Medical Colleges said NIH awarded 2,000 fewer multiyear-study grants this year than in 2025, worth a total of $200 million.

Key points

  • Pittsburgh’s nearly completed Alzheimer’s study lost NIH funding in its fifth year.
  • Researchers say more than $8 million had already been spent on the Pittsburgh study.
  • An Emory project on racial discrimination and health was also terminated before completion.
  • Scientists from Pittsburgh studies are among those suing NIH and HHS.
Read the original on PBS News ↗

More news

Loading stories…